According to previous publications, high expression PRDX3 is associated with advanced malignant phenotype and worse prognosis in hepatocellular carcinoma [26], endometrial cancer [27], and medulloblastoma [28]. The gene discussed is PRDX3; the disease is hepatocellular carcinoma.